Mapping of lymph node metastasis from esophagogastric junction tumors: a prospective nationwide multicenter study
Y Kurokawa, H Takeuchi, Y Doki, S Mine… - Annals of …, 2021 - journals.lww.com
Objective: The aim of the study was to determine the optimal extent of lymph node dissection
for the 2 histological types of esophagogastric junction (EGJ) tumors based on the incidence …
for the 2 histological types of esophagogastric junction (EGJ) tumors based on the incidence …
True esophagogastric junction adenocarcinoma: background of its definition and current surgical trends
T Kumamoto, Y Kurahashi, H Niwa, Y Nakanishi… - Surgery Today, 2020 - Springer
The definition of true esophagogastric junction (EGJ) adenocarcinoma and its surgical
treatment are debatable. We review the basis for the current definition and the Japanese …
treatment are debatable. We review the basis for the current definition and the Japanese …
Essential updates 2017/2018: Recent topics in the treatment and research of gastric cancer in Japan
S Komatsu, E Otsuji - Annals of gastroenterological surgery, 2019 - Wiley Online Library
Recent developments in diagnostic technology, accumulated clinical effort and established
evidence have boosted early detection and drastically improved early and long‐term …
evidence have boosted early detection and drastically improved early and long‐term …
Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma
H Yamashita, Y Seto, T Sano, H Makuuchi, N Ando… - Gastric Cancer, 2017 - Springer
Background Esophagogastric junction (EGJ) carcinoma has attracted considerable attention
because of the marked increase in its incidence globally. However, the optimal extent of …
because of the marked increase in its incidence globally. However, the optimal extent of …
Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for …
… Group (JCOG9502) Kurokawa Y Sasako M … - Journal of British …, 2015 - academic.oup.com
Background The optimal surgical approach for treatment of oesophagogastric junction (OGJ)
cancer is controversial. A randomized clinical trial (JCOG9502) comparing transhiatal (TH) …
cancer is controversial. A randomized clinical trial (JCOG9502) comparing transhiatal (TH) …
Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction
Y Kurokawa, N Hiki, T Yoshikawa, K Kishi, Y Ito, M Ohi… - Surgery, 2015 - Elsevier
Background Whether thorough mediastinal dissection is indicated in patients with Siewert
type II adenocarcinoma of the esophagogastric junction (EGJ) remains controversial. We …
type II adenocarcinoma of the esophagogastric junction (EGJ) remains controversial. We …
Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023
Y Kitagawa, S Matsuda, T Gotoda, K Kato, B Wijnhoven… - Gastric Cancer, 2024 - Springer
Background and purpose While advances in multimodal therapies have helped in improving
the outcome of patients with cancer of the esophagogastric junction (EGJ), current treatment …
the outcome of patients with cancer of the esophagogastric junction (EGJ), current treatment …
Postoperative complications after a transthoracic esophagectomy or a transhiatal gastrectomy in patients with esophagogastric junctional cancers: a prospective …
S Mine, Y Kurokawa, H Takeuchi, M Terashima… - Gastric Cancer, 2022 - Springer
Background Esophagogastric junction (EGJ) cancers are resected thorough esophagectomy
or gastrectomy, with the incidence of postoperative complications influenced by the chosen …
or gastrectomy, with the incidence of postoperative complications influenced by the chosen …
Significance of surgery for resectable M1 lymph node metastases without organ metastasis in esophageal carcinoma in the era of neoadjuvant treatment
S Igaue, R Nozaki, D Utsunomiya, Y Kubo… - Annals of Surgical …, 2024 - Springer
Background M1 esophageal carcinoma goes beyond localized disease and requires
treatment with systemic therapy. M1 status is primarily divided into two categories: M1 lymph …
treatment with systemic therapy. M1 status is primarily divided into two categories: M1 lymph …
Western strategy for EGJ carcinoma
S Giacopuzzi, M Bencivenga, J Weindelmayer… - Gastric Cancer, 2017 - Springer
In this paper, the epidemiological and clinicobiological behavior of esophagogastric junction
(EGJ) adenocarcinoma in the West is compared and contrasted to that in the East, and an …
(EGJ) adenocarcinoma in the West is compared and contrasted to that in the East, and an …